HSLVX | VISGX | HSLVX / VISGX | |
Total Expense Ratio | 0.87 | 0.19 | 458% |
Annual Report Gross Expense Ratio | 0.87 | 0.19 | 458% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | 0.124 | 4.750 | 3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 295M | 37.5B | 1% |
Annual Yield % from dividends | 1.34 | 0.40 | 333% |
Returns for 1 year | -8.98 | 12.89 | -70% |
Returns for 3 years | 11.64 | 36.55 | 32% |
Returns for 5 years | -14.75 | 34.76 | -42% |
Returns for 10 years | -4.26 | 145.21 | -3% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYOAX | 55.49 | -0.04 | -0.07% |
Rydex Biotechnology H | |||
RGCIX | 10.17 | -0.04 | -0.39% |
Russell Inv Global Infrastructure C | |||
TCIEX | 27.08 | -0.21 | -0.77% |
Nuveen International Eq Idx R6 | |||
GIRNX | 31.88 | -0.31 | -0.96% |
Goldman Sachs International Eq ESG Inv | |||
PGSGX | 18.01 | -0.23 | -1.26% |
JPMorgan Small Cap Growth A |